Product image of Mycophenolsäure Hexal (Mycophenolic Acid) supplied by GNH India

Mycophenolsäure Hexal

Active Ingredient:
Mycophenolic Acid
Origin:
EU

Mycophenolsäure Hexal (Mycophenolic Acid)

Mycophenolic Acid, the active ingredient in Mycophenolsäure Hexal, is an immunosuppressant presented as an oral formulation for oral use. It is used to prevent organ transplant rejection and to treat lupus nephritis in appropriate patients.

GNH India supplies Mycophenolsäure Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Hexal Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mycophenolic Acid acts as an immunosuppressive agent that inhibits lymphocyte proliferation, making it valuable in transplant and autoimmune settings.

  • Organ transplant rejection: helps prevent acute and chronic rejection of transplanted organs.
  • Lupus nephritis: reduces kidney inflammation and preserves renal function in patients with systemic lupus erythematosus.

How It Works

  • Mycophenolic Acid selectively and reversibly inhibits inosine monophosphate dehydrogenase (IMPDH), the key enzyme for guanosine nucleotide synthesis in lymphocytes. This depletion of guanosine nucleotides impairs DNA synthesis, thereby suppressing proliferation of B and T cells and reducing immune responses.

Side Effects

Mycophenolic Acid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: frequent loose stools.
  • Headache: transient cranial discomfort.
  • Abdominal pain: cramping or discomfort in the stomach area.
  • Infections: increased susceptibility to bacterial, viral or fungal infections.
  • Tremor: fine shaking of hands or limbs.

Serious or Rare Side Effects

  • Leukopenia: marked reduction in white blood cells.
  • Severe infections: opportunistic or life‑threatening infections.
  • Hepatic toxicity: elevated liver enzymes or hepatitis.
  • Malignancy: increased risk of certain cancers with long‑term use.
  • Progressive multifocal leukoencephalopathy (PML): rare demyelinating brain disease.

Precautions & Warnings

Before initiating therapy, clinicians should assess baseline laboratory values and patient risk factors.

  • Monitor blood counts: perform regular complete blood count tests.
  • Monitor liver function: check hepatic enzymes periodically.
  • Avoid in pregnancy: contraindicated due to teratogenic risk.
  • Use effective contraception: both male and female patients of reproductive potential must use reliable birth control.
  • Adjust in renal impairment: dose may need modification based on renal function.
  • Store at below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Mycophenolic Acid can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Azathioprine: additive bone‑marrow suppression.
  • Cyclosporine or tacrolimus: increased risk of nephrotoxicity and infections.
  • Live vaccines: may cause uncontrolled infection.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential for enhanced anticoagulant effect.
  • Antacids containing aluminum or magnesium: may reduce absorption of mycophenolic acid.

Frequently Asked Questions

Mycophenolsäure Hexal contains mycophenolic acid and is used to prevent rejection of transplanted organs and to treat lupus nephritis, an autoimmune kidney disease. It works by suppressing the immune system’s response that can damage the transplanted organ or kidney tissue.

Mycophenolic acid inhibits the enzyme inosine monophosphate dehydrogenase (IMPDH), which is essential for the synthesis of guanosine nucleotides in lymphocytes. By depleting these nucleotides, the drug blocks the proliferation of B and T cells, thereby reducing immune activity.

The specific dose of Mycophenolsäure Hexal is determined by the prescribing clinician based on the patient’s condition, weight, renal function and other individual factors. Only a qualified healthcare professional should set the dosing regimen.

Mycophenolsäure Hexal is classified as pregnancy category X, meaning it is contraindicated in pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as it may be excreted in breast milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycophenolic acid differs from calcineurin inhibitors such as cyclosporine or tacrolimus by targeting nucleotide synthesis rather than calcineurin signaling. This results in a distinct side‑effect profile, with less nephrotoxicity but a higher risk of gastrointestinal upset and bone‑marrow suppression.

Store Mycophenolsäure Hexal at temperatures below 25 °C in its original container, protecting it from moisture and direct light. Do not refrigerate or freeze the product unless otherwise directed by the manufacturer.

Mycophenolsäure Hexal is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The exact administration schedule—once or twice daily—depends on the prescriber’s instructions.

Serious risks include severe infections, leukopenia (low white‑blood‑cell count), liver toxicity, and rare but life‑threatening conditions such as progressive multifocal leukoencephalopathy (PML). Patients should be monitored regularly for these complications.

Mycophenolsäure Hexal should not be used by pregnant women, individuals with known hypersensitivity to mycophenolic acid, patients with severe renal impairment without dose adjustment, or anyone receiving live vaccines due to the risk of uncontrolled infection.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT